Does VALSARTAN Cause Nephrogenic anaemia? 29 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 29 reports of Nephrogenic anaemia have been filed in association with VALSARTAN (valsartan). This represents 0.1% of all adverse event reports for VALSARTAN.
29
Reports of Nephrogenic anaemia with VALSARTAN
0.1%
of all VALSARTAN reports
19
Deaths
20
Hospitalizations
How Dangerous Is Nephrogenic anaemia From VALSARTAN?
Of the 29 reports, 19 (65.5%) resulted in death, 20 (69.0%) required hospitalization, and 18 (62.1%) were considered life-threatening.
Is Nephrogenic anaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VALSARTAN. However, 29 reports have been filed with the FAERS database.
What Other Side Effects Does VALSARTAN Cause?
Drug ineffective (1,845)
Blood pressure increased (1,682)
Dizziness (1,527)
Headache (1,361)
Hypertension (1,341)
Acute kidney injury (1,301)
Dyspnoea (1,239)
Fatigue (1,156)
Malaise (1,139)
Hypotension (1,032)
What Other Drugs Cause Nephrogenic anaemia?
OMEPRAZOLE (2,873)
ESOMEPRAZOLE (2,869)
LANSOPRAZOLE (2,162)
PANTOPRAZOLE (2,118)
DEXLANSOPRAZOLE (825)
RABEPRAZOLE (241)
ESOMEPRAZOLE\NAPROXEN (107)
OMEPRAZOLE\SODIUM BICARBONATE (94)
SODIUM, DIBASIC\SODIUM, MONOBASIC (91)
DAPRODUSTAT (40)
Which VALSARTAN Alternatives Have Lower Nephrogenic anaemia Risk?
VALSARTAN vs VALTREX
VALSARTAN vs VAMOROLONE
VALSARTAN vs VANCOMYCIN
VALSARTAN vs VANDETANIB
VALSARTAN vs VARDENAFIL